Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 8,261 | 7,349 | 7,364 | 6,457 | 5,722 |
| Cost of Goods | 1,216 | 1,004 | 912 | 971 | 582 |
| Gross Profit | 7,045 | 6,345 | 6,452 | 5,486 | 5,140 |
| Operating Expenses | 14,841 | 15,088 | 15,538 | 18,129 | 20,026 |
| Operating Income | -7,580 | -8,739 | -8,174 | -11,672 | -14,304 |
| Interest Expense | 1,068 | 1,142 | 877 | 3 | 3 |
| Other Income | -1,461 | 7,479 | 4,726 | -1,528 | -21,388 |
| Pre-tax Income | -10,109 | -2,402 | -4,325 | -13,203 | -35,695 |
| Income Tax | 1 | 3 | -7 | -3 | 1 |
| Net Income Continuous | -10,110 | -2,405 | -4,318 | -13,200 | -35,696 |
| Net Income | $-10,108 | $-2,399 | $-4,332 | $-13,206 | $-35,696 |
| EPS Basic Total Ops | -0.38 | -0.12 | -0.21 | -0.60 | 29.78 |
| EPS Basic Continuous Ops | -0.35 | -0.09 | -0.18 | -0.57 | 25.63 |
| EPS Diluted Total Ops | -0.38 | -0.12 | -0.21 | -0.60 | 29.78 |
| EPS Diluted Continuous Ops | -0.35 | -0.09 | -0.18 | -0.57 | 25.63 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.40 | -0.21 | N/A | N/A |
| EBITDA(a) | $-7,209 | $-8,390 | $-7,713 | $-11,497 | $-14,110 |